Back to Search Start Over

Assay of protein S in systemic lupus erythematosus.

Authors :
Lawrie AS
Lloyd ME
Mohamed F
Irons S
Hughes GR
Savidge GF
Source :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 1995 Jun; Vol. 6 (4), pp. 322-4.
Publication Year :
1995

Abstract

Free protein S:Ag and protein S activity determined by clotting assay are often regarded as synonymous; however, in the study group of patients, abnormal protein S activity (PS:Act) results correlated poorly with abnormal free (PS:Ag(r2 = 0.164). Significantly none of the patients in whom lupus anticoagulant and low free protein S:Ag were detected were found to have low PS:Act. These results could not be explained by activated protein C resistance, suggesting that lupus anticoagulant may cause prolongation of the clotting time within the PS:Act assay and thus give falsely high results. As reduced levels of free protein S:Ag and/or protein S activity are considered risk factors of thrombosis in systemic lupus erythematosus, these findings question the suitability of the protein S activity assay for patients who may have phospholipid antibodies.

Details

Language :
English
ISSN :
0957-5235
Volume :
6
Issue :
4
Database :
MEDLINE
Journal :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Publication Type :
Academic Journal
Accession number :
7548680
Full Text :
https://doi.org/10.1097/00001721-199506000-00005